Spar’s historical competitive strengths are now its competitive weakness – but the winds of change are blowing, which means ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix", "the Company") today announces that its prostate cancer PET[1] ...

Live Updates Live Coverage Has Ended Analyst Call Roundup 6:18 pm by Here’s a roundup of the most recent analyst calls on ...

Opinion: Foley & Lardner attorneys say businesses must be strategic in using generative AI platforms to create logos and ...

The Motley Fool. DATE Tuesday, June 3, 2025 at 4:30 p.m. ET Read More: Earn up to $845 cash back this year just by changing how you pay at Costco! Learn more here. CALL PARTICIPANTS Chair, President, ...

Good day and thank you for standing by. Welcome to the Nutanix Third Quarter 2025 Earnings Conference Call. At this time, all ...

The acquisition includes a rare immunology disease medicine, Ayvakit/Ayvakyt (avapritinib), approved in the US and the EU, and a promising advanced and early-stage immunology pipeline. Furthermore, ...

GitLab is poised for strong growth with AI monetization, rising premium adoption, and a $125 PT on FY27 upside. See why GTLB ...

On Thursday May 22, the House of Representatives passed the One Big Beautiful Bill Act (H.R. 1, hereafter the “Bill”). The ...

Cardlytics offers compelling upside as high-margin Amex channel expansion and engagement-based pricing drive structural EBITDA recovery. See why CDLX stock is a Buy.

If you've found yourself owing an increasingly large set of tools, making sure nothing goes missing or gets stolen will ...